Zobrazeno 1 - 10
of 10
pro vyhledávání: '"E Sh, Botsvadze"'
Publikováno v:
Terapevticheskii arkhiv. 63(11)
A study was made of the therapeutic efficacy of human leukocytic interferon (HLI) and leikinferon in the treatment of HBV- and HDV-infection. 21 patients were placed under observation. Of these, 6 presented with lingering hepatitis B (HB), 8 with chr
Publikováno v:
Terapevticheskii arkhiv. 62(2)
A study was made of HB-virus infection markers in 438 patients of different age with hepatitis B. Highly sensitive methods based on the test systems manufactured in this country and abroad were employed. The authors established the diagnostic importa
Autor:
V I, Pokrovskiĭ, A V, Zmyzgova, E Sh, Botsvadze, M A, Andreĭchin, V M, Frolov, R T, Murzabaeva, A P, Mesniankin, L N, Kokareva, V V, Malinovskaia
Publikováno v:
Terapevticheskii arkhiv. 62(2)
The clinical trials of alpha 2-interferon (alpha 2-IF) (reaferon) in 412 patients with acute viral hepatitis B (AVHB) permitted the establishment of the optimal therapeutic dose and the schedule for the drug use. The drug tolerance appeared satisfact
Publikováno v:
Terapevticheskii arkhiv. 58(2)
Patients of different age, among them 103 with viral hepatitis B and 120 with viral hepatitis A, were examined for immunoregulatory subpopulations of T lymphocytes and for the effects of HBsAg preparations and human liver-specific lipoprotein (LSL) o
Publikováno v:
Terapevticheskii arkhiv. 61(11)
Publikováno v:
Pediatriia. (1)
Publikováno v:
Klinicheskaia meditsina. 59(2)
Publikováno v:
Sovetskaia meditsina. (2)
The detectability of delta-infection among patients with HB virus infections and their effects on the course of hepatitis B are discussed. Anti-delta were detected in 25.2% of 111 patients with HB virus infections. The course of the disease was more
Publikováno v:
Laboratornoe delo. (12)
Publikováno v:
Terapevticheskii arkhiv. 60(8)
The therapeutic efficacy of human leucocytic alpha-interferon and combiferon produced in the N.F. Gamaleya Institute of Epidemiology and Microbiology, was assessed in 27 patients with different types of hepatitis B and in 30 controls. A marked clinic